DETERMINATION OF ISATIN, AN ENDOGENOUS MONOAMINE-OXIDASE INHIBITOR, IN URINE AND TISSUES OF RATS BY HPLC

Citation
N. Hamaue et al., DETERMINATION OF ISATIN, AN ENDOGENOUS MONOAMINE-OXIDASE INHIBITOR, IN URINE AND TISSUES OF RATS BY HPLC, General pharmacology, 30(3), 1998, pp. 387-391
Citations number
18
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
03063623
Volume
30
Issue
3
Year of publication
1998
Pages
387 - 391
Database
ISI
SICI code
0306-3623(1998)30:3<387:DOIAEM>2.0.ZU;2-R
Abstract
1. We have previously identified isatin as one of the endogenous monoa mine oxidase (MAO) inhibitors in the urine and the brain of stroke-pro ne spontaneously hypertensive rats (SHRSP), using gas chromatography m ass spectrometry (GC-MS). 2. In this study, we attempted to develop a convenient assay to determine isatin using high performance liquid chr omatography with an ultraviolet detector (HPLC-UV). The standard curve for authentic isatin was linear at a range from 2 to 20 nmol per ml, The coefficient of variance was within 3% for both intra assay and int er assay. The sensitivity was 20 pmol per 10 mu l of urine sample.3. I satin concentration correlated significantly and positively with endog enous MAO activity (tribulin-like activity) in both urine (r = 0.924, P < 0.001) and kidney extracts (r = 0.862, P < 0.01). There was a sign ificant difference in urinary isatin between Wistar Kyoto rats (WKY) a nd SHRSP. Oral administration of isatin increased urinary isatin conce ntration and systolic blood pressure in WKY. 4. Determination of isati n using HPLC-UV may be useful for elucidating role of isatin in variou s conditions of stress and disease. (C) 1998 Elsevier Science Inc.